Eli Lilly v Actavis. Mark Engelman Head of Intellectual Property

Size: px
Start display at page:

Download "Eli Lilly v Actavis. Mark Engelman Head of Intellectual Property"

Transcription

1 Eli Lilly v Actavis Mark Engelman Head of Intellectual Property mark.engelman@hardwicke.co.uk

2 Topics 1. Literalism 2. Ely Lilly v Actavis The Facts 3. Catnic Components Ltd v Hill & Smith Ltd [1982] RPC Improver Corpn v Remington Consumer Products Ltd [1990] FSR Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9 6. Ely Lilly v Activis The Law 7. Ely Lilly v Activis The Effects

3 1. Literalism Definition of LITERALISM adherence to the explicit substance of an idea or expression 'The question is,' said Alice, 'whether you can make words mean so many different things. Alice in Wonderland Lewis Carroll

4 2. Ely Lilly v Actavis The Facts Pemetrexed - an antitfolate in a disodium salt for carcinoma side effects ameliorated with vitamin B12

5 2. Ely Lilly v Actavis The Facts Actavis intended to launch its drug with (a) pemetrexed diacid, (b) pemetrexed ditromethamine, or (c) pemetrexed dipotassium but crucially not the disodium salt,

6 2. Ely Lilly v Actavis The Facts Eli Lilly argued the Actavis s product : (a) as an equivalent infringed its patent because it fell within the claims or (b) because the disodium salt is created in the course of manufacturing pemetrexed.

7 3. Catnic Components Ltd v Hill & Smith Ltd Distinction drawn between: textual infringement and infringement of the pith and marrow of the invention. "A patent specification should be given a purposive construction rather than a purely literal one understanding language in accordance with what a reasonable person would understand the author to be using the words to mean

8 3. Catnic Components Ltd v Hill & Smith Ltd

9 4. Improver Corpn v Remington Consumer Products Ltd

10 4. Improver Corpn v Remington Consumer Products Ltd Patent covered a depilatory device having a curved "helical spring" driven by a motor. The spring when rotated gripped hairs between its coils and plucked them from the skin. The alleged infringement replaced the spring with a rubber rod having slits in its surface. The question was whether the slitted rubber rod was "a helical spring".

11 4. Improver Corpn v Remington Consumer Products Ltd the Improver Questions : (1) Does a variant (to an element of a patent claim) have a material effect upon the way the invention works? If yes, the variant is outside the claim. If no (2) Would this (ie, that the variant had no material effect) have been obvious at the date of publication of the patent to a reader skilled in the art? If no, the variant is outside the claim. If yes (3) Would the reader skilled in the art nevertheless have understood from the language of the claim that the patentee intended that strict compliance with the primary meaning was an essential requirement of the invention? If yes, the variant is outside the claim.

12 4. Improver Corpn v Remington Consumer Products Ltd On the other hand, a negative answer to the last question would lead to the conclusion that the patentee was intending the word or phrase to have not a literal, but a figurative meaning (the figure being a form of synecdoche or metonymy) denoting a class of things which included the variant and the literal meaning, the latter being perhaps the most perfect, best-known or striking example of the class.

13 Held: (i) (ii) 4. Improver Corpn v Remington Consumer Products Ltd the change to a rubber rod had no material effect on the way the invention worked; and it would have been obvious to an expert that the rubber rod would work in the same way; (iii) but (iii) the expert would have understood from the patent that the patentee meant to confine his claim to a "helical spring", in its primary meaning and not in a wide generic sense. For this last reason, the rubber rod did not infringe.

14 Art.69(1) 4. Improver Corpn v Remington Consumer Products Ltd should not be interpreted as meaning that the extent of the protection is to be understood as that defined by the strict, literal meaning of the wording used in the claims, the description and drawings being employed only for the purpose of resolving an ambiguity found in the claims.

15 4. Improver Corpn v Remington Consumer Products Ltd Art.69(1) Nor should it be taken to mean that the claims serve only as a guideline and that the actual protection conferred may extend to what, from a consideration of the description and drawings by a person skilled in the art, the patent proprietor has contemplated. On the contrary, it is to be interpreted as defining a position between these extremes which combines a fair protection for the patent proprietor with a reasonable degree of legal certainty for third parties.

16 4. Improver Corpn v Remington Consumer Products Ltd Art.69(2) - Equivalents For the purpose of determining the extent of protection conferred by a European patent, due account shall be taken of any element which is equivalent to an element specified in the claims.

17 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd Technologies employed by the two parties for producing the hormone erythropoietin

18 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd C: a DNA sequence for use in securing the expression of EPO in a host cell versus D: TKT method did not involve using a "DNA sequence for use in securing expression (of EPO) in a host cell"

19 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd D made EPO by an endogenous DNA sequence coding for EPO in a human cell into which an exogenous promoter sequence has been inserted

20 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd to adopt a principle of construction which actually gave effect to what the person skilled in the art would have understood the patentee to be claiming.

21 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd Interpreting the claims of the Amgen patent in the context of its specification, the claims were concerned with the expression of EPO by a gene which is exogenous to the cell. But the genes which express EPO in cells by the TKT process are not exogenous.

22 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd The HL rejected literalism over a purposive construction (adopting Catnic): to adopt a principle of construction which actually gave effect to what the person skilled in the art would have understood the patentee to be claiming. (not what the author of the words thought them to mean cf Alice)

23 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd Additionally, if a claim is intended to cover products or processes which involve the use of technology unknown at the time the claim was drafted, then the patent specification and claims based thereon should be drafted so that a person skilled in the art would understand the description in a way which was sufficiently general to include the new technology.

24 5. Kirin-Amgen Inc v Hoechst Marion Roussel Ltd But Kiren-Amgen was not really an equivalents type case.

25 6. Ely Lilly v Activis The Law Activis is: Does K2=Na2?

26 6. Ely Lilly v Activis The Law Claim 1: Use of pemetrexed disodium in the manufacture of a medicament for use in combination therapy for inhibiting tumor growth in mammals wherein said medicament is to be administered in combination with vitamin B12 or a pharmaceutical derivative thereof [which it then specifies].

27 6. Ely Lilly v Activis The Law The central contention between Eli Lilly and Actavis was whether the words pemetrexed disodium were to be read literally or purposively? If the latter, they include either a pemetrexed diacid or a pemetrexed salt with vitamin B12, which represents the essence of the patent.

28 Neuberger LJ: 6. Ely Lilly v Activis The Law (i) does the variant infringe any of the claims as a matter of normal interpretation; and, if not, (ii) does the variant nonetheless infringe because it varies from the invention in a way or ways which is or are immaterial? (iii) If the answer to either issue is yes, there is an infringement; otherwise, there is not.

29 6. Ely Lilly v Activis The Law What does immaterial mean? Would it be obvious to the person skilled in the art, reading the patent at the priority date, but knowing that the variant achieves substantially the same result as the invention, that it does so in substantially the same way as the invention?

30 6. Ely Lilly v Activis The Law Now applying the facts: Question 1: Does the variant infringe any of the claims as a matter of normal interpretation;

31 6. Ely Lilly v Activis The Law Now applying the facts: Answer 1: No

32 6. Ely Lilly v Activis The Law Now applying the facts: Question 2: Would it be obvious to the person skilled in the art, reading the patent at the priority date, but knowing that the variant achieves substantially the same result as the invention, that it does so in substantially the same way as the invention?

33 6. Ely Lilly v Activis The Law Now applying the facts: Answer 2: The chemical variants in Actavis' product: (a) pemetrexed diacid, (b) pemetrexed ditromethamine and (c) pemetrexed dipotassium were equivalents of the disodium salt. They did not have a material effect upon the way the invention works.

34 6. Ely Lilly v Activis The Law Now applying the facts: Answer 2, Rule 1: Lord Neuberger drew upon references in its specification to the words other anti-folate drugs which have a similar effect to pemetrexed disodium.

35 6. Ely Lilly v Activis The Law Now applying the facts: Answer 2, Rule 2: He refused to take into account any exchanges between the patent office and the patentee during the prosecution of the patent.

36 6. Ely Lilly v Activis The Law Now applying the facts: Question 3: If the answer to either issue is yes, there is an infringement; otherwise, there is not. Thus, there was an infringement.

37 7. Ely Lilly v Activis The Effects The doctrine of equivalents is alive and well The prosecution history is irrelevant The wording of the specification remains important Invalidity might be dealt with the same way is this patent claim invalid because the prior art has an equivalent

Dawn of an English Doctrine of Equivalents: immaterial variants infringe

Dawn of an English Doctrine of Equivalents: immaterial variants infringe Dawn of an English Doctrine of Equivalents: immaterial variants infringe November 2017 The Supreme Court reinvents patent infringement The Supreme Court s landmark judgment in Actavis v Eli Lilly is a

More information

Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis transmutes sodium into potassium but will it provide gold for patentees?

Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis transmutes sodium into potassium but will it provide gold for patentees? WHITEHEAD AND JACKSON : ALCHEMY IN THE UK: THE SUPREME COURT IN ELI LILLY v ACTAVIS TRANSMUTES SODIUM INTO POTASSIUM : VOL 16 ISSUE 3 BSLR 135 Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis

More information

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT)

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT) Litigators Asscociation EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT) ACTAVIS V LILLY MILAN, 14 MAY 2018 EUROPEAN PATENT LITIGATORS ASSOCIATION Actavis UK Limited and others (Appellants) v Eli Lilly and

More information

Actavis in the Antipodes a doctrine of equivalents for New Zealand?

Actavis in the Antipodes a doctrine of equivalents for New Zealand? Actavis in the Antipodes a doctrine of equivalents for New Zealand? 1. Abstract The United Kingdom Supreme Court decision in Actavis UK Limited and others v Eli Lilly and Company (Actavis) substantially

More information

Patents Act 1977, Secs. 125 (1), (3) and 130 (7); European Patent Convention, Art "Epilady United Kingdom"

Patents Act 1977, Secs. 125 (1), (3) and 130 (7); European Patent Convention, Art Epilady United Kingdom 21 IIC 561 (1990) UNITED KINGDOM Patents Act 1977, Secs. 125 (1), (3) and 130 (7); European Patent Convention, Art. 69 - "Epilady United Kingdom" 1. The question whether a patent infringement is given

More information

ACTAVIS UK LTD v ELI LILLY & CO

ACTAVIS UK LTD v ELI LILLY & CO 38 [2016] R.P.C. 2 ACTAVIS UK LTD v ELI LILLY & CO COURT OF APPEAL Longmore, Kitchin and Floyd L.JJ.: 9-12 March and 25 June 2015 H1 [2015] EWCA Civ 555; [2016] R.P.C. 2 Patent European Patent Declaration

More information

Keywords: patent, construction, infringement, Amgen, equivalents, protocol

Keywords: patent, construction, infringement, Amgen, equivalents, protocol William Cook is a specialist intellectual property solicitor, and advises clients on all aspects of IP protection, licensing and enforcement, with particular focus on patent matters. In recent years, he

More information

ACTAVIS V ELI LILLY SHOULD WE HAVE SEEN IT COMING?

ACTAVIS V ELI LILLY SHOULD WE HAVE SEEN IT COMING? ACTAVIS V ELI LILLY SHOULD WE HAVE SEEN IT COMING? GORDON D HARRIS HEAD OF IP GOWLING WLG (UK) LLP There are a number of important aspects to the Supreme Court decision in Actavis v Eli Lilly 1, but the

More information

Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art "Kastner"

Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art Kastner 28 IIC 114 (1997) UNITED KINGDOM Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art. 69 - "Kastner" 1. A patent specification must be construed as a

More information

Actavis v Eli Lilly - Are we clear now?

Actavis v Eli Lilly - Are we clear now? Actavis v Eli Lilly - Are we clear now? Patrick Kelleher Much has been written about the implications of the July 2017 Supreme Court decision in Actavis v Eli Lilly in which Lord Neuberger delivered the

More information

Lee Tat Cheng v Maka GPS Technologies Pte Ltd

Lee Tat Cheng v Maka GPS Technologies Pte Ltd This judgment is subject to final editorial corrections approved by the court and/or redaction pursuant to the publisher s duty in compliance with the law, for publication in LawNet and/or the Singapore

More information

Doctrine of Equivalents: Recent Developments in Germany

Doctrine of Equivalents: Recent Developments in Germany Doctrine of Equivalents: Recent Developments in Germany Young EPLAW Congress Brussels 24 April 2017 Ole Dirks decisively different Introduction Legal framework: Art. 69 para. 1 EPC / Sec. 14 German Patents

More information

Doctrine of Equivalents: Recent Developments in Switzerland

Doctrine of Equivalents: Recent Developments in Switzerland Doctrine of Equivalents: Recent Developments in Switzerland Young EPLAW Congress Brussels 24 April 2017 Peter Ling 2 1 Introduction Federal Patent Court (2012-) Statutory basis of equivalence - "imitation

More information

Reversal decision of 15/10/2018 Case No /2017

Reversal decision of 15/10/2018 Case No /2017 COURT OF MILAN Specialised business division Division A The Court s Panel, represented by the following Judges: Mr Claudio Marangoni Ms Anna Bellesi Ms Alima Zana President and Judge rapporteur Judge Judge

More information

Inside IP. Intelligent patents for artificial intelligence. European Intellectual Property Attorneys PAGE 11

Inside IP. Intelligent patents for artificial intelligence. European Intellectual Property Attorneys PAGE 11 Inside IP Venner Shipley s Intellectual Property Magazine Autumn/Winter 2017 Intelligent patents for artificial intelligence PAGE 11 Actavis v Eli Lilly Supreme Court Decision PAGE 1 The growing influence

More information

RETAINING THE CATNIC/IMPROVER APPROACH IN PATENT LAW

RETAINING THE CATNIC/IMPROVER APPROACH IN PATENT LAW Published on e-first 17 October 2018 RETAINING THE CATNIC/IMPROVER APPROACH IN PATENT LAW Why Singapore Should Not Adopt the Doctrine of Equivalents In 2017, the UK Supreme Court departed from an established

More information

OPINIONS OF THE LORDS OF APPEAL

OPINIONS OF THE LORDS OF APPEAL HOUSE OF LORDS SESSION 2003 04 [2004] UKHL 46 on appeal from: [2002] EWCA Civ 1096 OPINIONS OF THE LORDS OF APPEAL FOR JUDGMENT IN THE CAUSE Kirin-Amgen Inc and others (Appellants) v. Hoechst Marion Roussel

More information

THE DOCTRINE OF EQUIVALENTS IN VARIOUS PATENT REGIMES-DOES ANYBODY HAVE IT RIGHT?

THE DOCTRINE OF EQUIVALENTS IN VARIOUS PATENT REGIMES-DOES ANYBODY HAVE IT RIGHT? Yale Journal of Law and Technology Volume 11 Issue 1 Yale Journal of Law and Technology Article 9 1-1-2009 THE DOCTRINE OF EQUIVALENTS IN VARIOUS PATENT REGIMES-DOES ANYBODY HAVE IT RIGHT? Nicholas Pumfrey

More information

PATENT. Vexed pemetrexed UK Supreme Court rewrites the law on scope of patent protection. no.60. Full Story Page 02. August 2017 In this issue:

PATENT. Vexed pemetrexed UK Supreme Court rewrites the law on scope of patent protection. no.60. Full Story Page 02. August 2017 In this issue: PATENT no.60 August 2017 In this issue: Impression Product 05 v Lexmark International US Supreme Court changes the law on patent exhaustion An illusion of clarity 06 The new Rule 28(2) EPC First technical

More information

A Road to Unification: Patent Litigation in the United Kingdom

A Road to Unification: Patent Litigation in the United Kingdom Fordham Intellectual Property, Media and Entertainment Law Journal Volume 23 Volume XXIII Number 2 Volume XXIII Book 2 Article 7 2013 A Road to Unification: Patent Litigation in the United Kingdom 1990-2012

More information

Construction of second medical use claims. The Hon. Mr Justice Richard Arnold

Construction of second medical use claims. The Hon. Mr Justice Richard Arnold Construction of second medical use claims The Hon. Mr Justice Richard Arnold The problem Claim 1 of European Patent (UK) No. 0 934 061 reads: Use of [pregabalin] or a pharmaceutically acceptable salt thereof

More information

Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector

Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector 2012 LIDC Congress, Prague, 12 October 2012 Dr. Simon Holzer, Attorney-at-Law, Partner 3 October 2012 2 Introduction! Conflicting

More information

HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION

HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION 21 January 2016 Australia, Brisbane, Melbourne, Perth, Sydney

More information

Attention: Ms Chung Ka Yee 29 January Re: Feedback on Proposed Changes to Chapter 8 Of The Examination Guidelines For Patent Applications

Attention: Ms Chung Ka Yee 29 January Re: Feedback on Proposed Changes to Chapter 8 Of The Examination Guidelines For Patent Applications Intellectual Property Office Of Singapore 51 Bras Basah Road #01-01, Manulife Centre Singapore 189554 Attention: Ms Chung Ka Yee 29 January 2016 Dear Ka Yee, Re: Feedback on Proposed Changes to Chapter

More information

The Unitary Patent Plan Beta Update on National Case Law in Europe

The Unitary Patent Plan Beta Update on National Case Law in Europe The Unitary Patent Plan Beta Update on National Case Law in Europe Leythem Wall 28 November 2013 Declarations of Non-Infringement Article 15 of the Unified Patent Court (UPC) Agreement sets out the areas

More information

The Community Patent System Proposal and Patent Infringement Proceedings: An Eye towards Greater Harmonization in European Intellectual Property Law

The Community Patent System Proposal and Patent Infringement Proceedings: An Eye towards Greater Harmonization in European Intellectual Property Law Pace Law Review Volume 22 Issue 1 Winter 2001 Article 5 January 2001 The Community Patent System Proposal and Patent Infringement Proceedings: An Eye towards Greater Harmonization in European Intellectual

More information

F2050-C I TER ATIO AL COURT OF ARBITRATIO, EW DELHI. GOOD HEALTH COMPA Y I TELLECTUAL PROPERTY DEPARTME T OF MARU MEMORIAL FOR THE CLAIMA T

F2050-C I TER ATIO AL COURT OF ARBITRATIO, EW DELHI. GOOD HEALTH COMPA Y I TELLECTUAL PROPERTY DEPARTME T OF MARU MEMORIAL FOR THE CLAIMA T F2050-C I TER ATIO AL COURT OF ARBITRATIO, EW DELHI. 2010 GOOD HEALTH COMPA Y V. I TELLECTUAL PROPERTY DEPARTME T OF MARU MEMORIAL FOR THE CLAIMA T TABLE OF CO TE TS I DEX OF AUTHORITITES... 4 STATEME

More information

Current Patent Litigation Trends: UK and Germany

Current Patent Litigation Trends: UK and Germany Volume 26, Number 7 July 2012 Reproduced with permission from World Intellectual Property Report, 26 WIPR 40, 07/01/2012. Copyright 2012 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com

More information

IN THE INTERNATIONAL COURT OF ARBITRATION GOOD HEALTH COMPANY DIRECTOR OF IP, STATE OF MARU SUBMISSIONS OF COUNSEL FOR THE CLAIMANT

IN THE INTERNATIONAL COURT OF ARBITRATION GOOD HEALTH COMPANY DIRECTOR OF IP, STATE OF MARU SUBMISSIONS OF COUNSEL FOR THE CLAIMANT IN THE INTERNATIONAL COURT OF ARBITRATION BETWEEN: GOOD HEALTH COMPANY CLAIMANT -AND- DIRECTOR OF IP, STATE OF MARU RESPONDENT SUBMISSIONS OF COUNSEL FOR THE CLAIMANT DATE OF DOCUMENT: 10 th of September

More information

Second medical use or indication claims. Winnie Tham, Edmund Kok, Nicholas Ong

Second medical use or indication claims. Winnie Tham, Edmund Kok, Nicholas Ong Question Q238 National Group: Title: Contributors: Reporter within Working Committee: AIPPI SINGAPORE Second medical use or indication claims Winnie Tham, Edmund Kok, Nicholas Ong THAM, Winnie Date: 17

More information

An introduction to European intellectual property rights

An introduction to European intellectual property rights An introduction to European intellectual property rights Scott Parker Adrian Smith Simmons & Simmons LLP 1. Patents 1.1 Patentable inventions The requirements for patentable inventions are set out in Article

More information

THE SUPREME COURT OF APPEAL OF SOUTH AFRICA JUDGMENT ORICA MINING SERVICES SA (PTY) LTD ELBROC MINING PRODUCTS (PTY) LTD

THE SUPREME COURT OF APPEAL OF SOUTH AFRICA JUDGMENT ORICA MINING SERVICES SA (PTY) LTD ELBROC MINING PRODUCTS (PTY) LTD THE SUPREME COURT OF APPEAL OF SOUTH AFRICA JUDGMENT Reportable Case No: 233/2016 In the matter between: ORICA MINING SERVICES SA (PTY) LTD APPELLANT and ELBROC MINING PRODUCTS (PTY) LTD RESPONDENT Neutral

More information

PATENT CLAIM INTERPRETATION What is the Game in North America? (An Outline) By J. Alan Aucoin

PATENT CLAIM INTERPRETATION What is the Game in North America? (An Outline) By J. Alan Aucoin PATENT CLAIM INTERPRETATION What is the Game in North America? (An Outline) By J. Alan Aucoin With apologies for my title (and a nod) to a former Chief Judge of the U.S. Federal Circuit, my presentation

More information

Chapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3))

Chapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3)) Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part IV Chapter 2 Amendment Adding New Matter Chapter 2 Amendment Adding New Matter

More information

Where are we now with plausibility?

Where are we now with plausibility? /0/7 Where are we now with plausibility? Jin Ooi, Allen & Overy LLP (UK) Monday April 7 What s the big deal with plausibility? For the first time since the first edition in 188, the 18 th edition of Terrell

More information

Second medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines

Second medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines Question Q238 National Group: Title: Contributors: Reporter within Working Committee: PHILIPPINES Second medical use or indication claims Mr. Alex Ferdinand FIDER Mr. Antonio Ray ORTIGUERA Angara Abello

More information

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law Elisabetta Papa Società Italiana Brevetti S.p.A. Functional claiming is allowed under the EPC and related case-law, with a few disclosure-specific

More information

Section I New Matter. (June 2010) 1. Relevant Provision

Section I New Matter. (June 2010) 1. Relevant Provision Section I New Matter 1. Relevant Provision Patent Act Article 17bis(3) reads: any amendment of the description, scope of claims or drawings shall be made within the scope of the matters described in the

More information

Bangkok, August 22 to 26, 2016 (face-to-face session) August 29 to October 30, 2016 (follow-up session)

Bangkok, August 22 to 26, 2016 (face-to-face session) August 29 to October 30, 2016 (follow-up session) WIPO National Patent Drafting Course organized by the World Intellectual Property Organization (WIPO) in cooperation with the Department of Intellectual Property (DIP), Ministry of Commerce of Thailand

More information

"And then there were. 18 th Annual Patent Seminar. Gordon Harris, Legal01# v1[GDH]

And then there were. 18 th Annual Patent Seminar. Gordon Harris, Legal01# v1[GDH] "And then there were three " Gordon Harris, 2016 18 th Annual Patent Seminar Legal01#57492496v1[GDH] Dedicated to the memory of David Keltie 1938 2016 1 CONTENTS Clause Heading Page 1 Introduction... 3

More information

International Court of Arbitration at New Delhi, India THE CASE OF COMPULSORY LICENSE AND PATENT INFRINGEMENT UNDER TRIPS GOOD HEALTH COMPANY

International Court of Arbitration at New Delhi, India THE CASE OF COMPULSORY LICENSE AND PATENT INFRINGEMENT UNDER TRIPS GOOD HEALTH COMPANY 5 th LAWASIA INTERNATIONAL MOOT 2010 International Court of Arbitration at New Delhi, India THE CASE OF COMPULSORY LICENSE AND PATENT INFRINGEMENT UNDER TRIPS GOOD HEALTH COMPANY (CLAIMANT) VS. DIRECTOR

More information

Intellectual Property Department Hong Kong, China. Contents

Intellectual Property Department Hong Kong, China. Contents Intellectual Property Department Hong Kong, China Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 3 Section 3: Experimental use and/or scientific research... 3 Section

More information

INTERNATIONAL COURT OF ARBITRATION NEW DELHI, INDIA GOOD HEALTH COMPANY CLAIMANT DIRECTOR OF INTELLECTUAL PROPERTY, STATE OF MARU RESPONDENT

INTERNATIONAL COURT OF ARBITRATION NEW DELHI, INDIA GOOD HEALTH COMPANY CLAIMANT DIRECTOR OF INTELLECTUAL PROPERTY, STATE OF MARU RESPONDENT INTERNATIONAL COURT OF ARBITRATION NEW DELHI, INDIA 2010 GOOD HEALTH COMPANY CLAIMANT v. DIRECTOR OF INTELLECTUAL PROPERTY, STATE OF MARU RESPONDENT MEMORIAL FOR THE RESPONDENT TABLE OF CONTENTS TABLE

More information

Second medical use or indication claims. [Please insert name last name in CAPITAL letters please]

Second medical use or indication claims. [Please insert name last name in CAPITAL letters please] Question Q238 National Group: Title: Contributors: Reporter within Working Committee: New Zealand Second medical use or indication claims Michael BROWN, Partner Helen BELLCHAMBERS, Associate A J Park [Please

More information

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility The Patent Examination Manual Section 10: Meaning of useful An invention, so far as claimed in a claim, is useful if the invention has a specific, credible, and substantial utility. Meaning of useful 1.

More information

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal 1. Small molecules 1.1 Product and process claims Classic drug development works with small, chemically manufactured

More information

English Language Translation Entry into New Zealand PCT National Phase

English Language Translation Entry into New Zealand PCT National Phase 2009 Business Updates Request for postponement of acceptance under section 20(1) of the Patents Act 1953 Applicants may at any time prior to acceptance request that a patent application not be accepted

More information

Suzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup.

Suzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup. Differences between US and EU Patent Laws that Could Cost You and Your Startup Suzannah K. Sundby United States canady + lortz LLP Europe David Read UC Center for Accelerated Innovation October 26, 2015

More information

The use of prosecution history in post-grant patent proceedings. Maria CRUZ GARCIA, Isabel FRANCO, João JORGE, Teresa SILVA GARCIA

The use of prosecution history in post-grant patent proceedings. Maria CRUZ GARCIA, Isabel FRANCO, João JORGE, Teresa SILVA GARCIA Question Q229 National Group: Title: Portugal The use of prosecution history in post-grant patent proceedings Contributors: Filipe BAPTISTA, Maria CRUZ GARCIA, Isabel FRANCO, João JORGE, Teresa SILVA GARCIA

More information

Actavis Group v. Eli Lilly: Cross-Border Infringement Jurisdiction

Actavis Group v. Eli Lilly: Cross-Border Infringement Jurisdiction Actavis Group v. Eli Lilly: Cross-Border Infringement Jurisdiction Earlier this week in Actavis Group HF v. Eli Lilly & Co., [2012] EWHC 3316 (Pat)(High Court 2012)(Arnold, J.), a trial court has ruled

More information

Claims and Determining Scope of Protection

Claims and Determining Scope of Protection Introduction 2014 APAA Patents Committee Questionnaire Claims and Determining Scope of Protection for Taiwan Group Many practitioners and users of the patent system believe that it is a fairly universal

More information

Judgment of 20 October 2017 First Civil Law Chamber

Judgment of 20 October 2017 First Civil Law Chamber [STAMP] Federal Supreme Court [Bundesgericht] Tribunal federal Tribunale federale Tribunal federal Case No. R11301CH00 30 October 2017 PA/RA CHI OST ERF JED 4A_208/2017 Judgment of 20 October 2017 First

More information

Law on the protection of inventions No. 50/2008 of the Republic of Moldova can be found at:

Law on the protection of inventions No. 50/2008 of the Republic of Moldova can be found at: The answers to this questionnaire have been provided on behalf of: Country: Republic of Moldova... Office: The State Agency on Intellectual Property... Person to be contacted: Name: Cicinova Olga... Title:

More information

AIPLA QUARTERLY JOURNAL

AIPLA QUARTERLY JOURNAL AIPLA QUARTERLY JOURNAL Volume 41, Number 3 Page 553 Summer 2013 STUDENT NOTE JUST ABOUT EQUIVALENT: A COMPARATIVE ANALYSIS OF THE DOCTRINES OF EQUIVALENTS IN THE UNITED STATES AND INTERNATIONAL JURISDICTIONS

More information

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position Dr Peter Meier-Beck Presiding Judge at the Bundesgerichtshof Honorary Professor at the University of Düsseldorf FICPI

More information

The Patent Examination Manual. Section 7: Meaning of inventive step

The Patent Examination Manual. Section 7: Meaning of inventive step The Patent Examination Manual Section 7: Meaning of inventive step An invention, so far as claimed in a claim, involves an inventive step if it is not obvious to a person skilled in the art, having regard

More information

Paper No Entered: September 30, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE

Paper No Entered: September 30, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE Trials@uspto.gov Paper No. 31 571.272.7822 Entered: September 30, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD APOTEX INC. and APOTEX CORP., Petitioner, v. ELI

More information

APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY

APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY 1. The decisions of two differently constituted High Courts in Kimberly-Clark Australia Pty Ltd v Arico Trading International Pty Ltd (2001) 207 CLR

More information

ti Litigating Patents Overseas: Country Specific Considerations Germany There is no "European" litigation system.

ti Litigating Patents Overseas: Country Specific Considerations Germany There is no European litigation system. Wolfgang Festl-Wietek of Viering Jentschura & Partner Speaker 11: 1 LSI Law Seminars International ti Litigating Patents Overseas: Country Specific Considerations Germany by Wolfgang Festl-Wietek Viering,

More information

CHAPTER V PATENT SPECIFICATION AND CLAIMS

CHAPTER V PATENT SPECIFICATION AND CLAIMS CHAPTER V PATENT SPECIFICATION AND CLAIMS This chapter deals with the specification and claiming requirements of patent applications. Patents are granted with a significant involvement of the patent office.

More information

THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET?

THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET? THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET? The Drug Price Competition and Patent Term Restoration Act of 1984 (also known as the Hatch-Waxman Act) was enacted for the

More information

THE REPLACEMENT OF THE DOCTRINE OF PITH AND MARROW BY THE CATNIC TEST IN ENGLISH PATENT LAW: A HISTORICAL EVALUATION RAYMOND MNYAMEZELI MLUNGISI ZONDO

THE REPLACEMENT OF THE DOCTRINE OF PITH AND MARROW BY THE CATNIC TEST IN ENGLISH PATENT LAW: A HISTORICAL EVALUATION RAYMOND MNYAMEZELI MLUNGISI ZONDO THE REPLACEMENT OF THE DOCTRINE OF PITH AND MARROW BY THE CATNIC TEST IN ENGLISH PATENT LAW: A HISTORICAL EVALUATION by RAYMOND MNYAMEZELI MLUNGISI ZONDO submitted in accordance with the requirements for

More information

Application of Doctrine of Equivalents in Patent Infringement Disputes

Application of Doctrine of Equivalents in Patent Infringement Disputes Journal of Intelletual Property Rights Vol 12, July 2007, pp 410-421 Application of Doctrine of Equivalents in Patent Infringement Disputes Tarun Mathur National Law University, NH-65, Near Mandore, Jodhpur

More information

The Myriad patent litigation Patentability of DNA molecules

The Myriad patent litigation Patentability of DNA molecules The Myriad patent litigation Patentability of DNA molecules Presentation to the SIPO Delegation SIPO/US Bar Liaison Council with ACPAA Joint Symposium at Cardozo Law School New York City, June 3, 2013

More information

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of: The answers to this questionnaire have been provided on behalf of: Country: Office: Republic of Poland Patent Office of the Republic of Poland Person to be contacted: Name: Piotr Czaplicki Title: Director,

More information

Evidence in EPO Proceedings. Dr. Joachim Renken Madrid, November 14, 2016

Evidence in EPO Proceedings. Dr. Joachim Renken Madrid, November 14, 2016 Evidence in EPO Proceedings Dr. Joachim Renken Madrid, November 14, 2016 General Principles Who carries the burden of proof during prosecution? Who bears the burden during opposition? Exceptions Who bears

More information

Basic Patent Information from the USPTO (Redacted) November 15, 2007

Basic Patent Information from the USPTO (Redacted) November 15, 2007 Basic Patent Information from the USPTO (Redacted) November 15, 2007 What Is a Patent? A patent for an invention is the grant of a property right to the inventor, issued by the United States Patent and

More information

Frequently Asked Questions. Trade/service marks: What is a trade/service mark?

Frequently Asked Questions. Trade/service marks: What is a trade/service mark? Frequently Asked Questions Trade/service marks: What is a trade/service mark? Is a distinctive sign that serves to distinguish the goods and/or services of one enterprise from those of other enterprises.

More information

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University I. Steps in the Process of Declaration of Your Invention or Creation. A. It is the policy of East

More information

Plausibility, 2nd medical use and late amendments - The Dutch perspective after UK SC 14 Nov 2018 pregabalin case

Plausibility, 2nd medical use and late amendments - The Dutch perspective after UK SC 14 Nov 2018 pregabalin case 20 November 2018 Pregabalin UCL Pregabalin UCL Plausibility, 2nd medical use and late amendments - The Dutch perspective after UK SC 14 Nov 2018 pregabalin case Judge Edger F. Brinkman, senior judge, Court

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit 05-1062 LIZARDTECH, INC., and Plaintiff-Appellant, REGENTS OF THE UNIVERSITY OF CALIFORNIA, v. Plaintiffs EARTH RESOURCE MAPPING, INC., and EARTH

More information

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems - comparison and interaction between the EPO appeal system and the national judicial systems 22 nd Annual Fordham IP Law & Policy Conference 24 April 2014, NYC by Dr. Klaus Grabinski Federal Court of Justice,

More information

Update on the CRISPR IP Saga and lessons to be learnt. Claire Irvine and Cath Coombes #healthcare #intellectualproperty

Update on the CRISPR IP Saga and lessons to be learnt. Claire Irvine and Cath Coombes #healthcare #intellectualproperty Update on the CRISPR IP Saga and lessons to be learnt Claire Irvine and Cath Coombes #healthcare #intellectualproperty Background In the last 6 years this field has generated: 600+ pending European patent

More information

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of: The answers to this questionnaire have been provided on behalf of: Country: Austria... Office: Austrian Patent Office (APO)... Person to be contacted: Name:... Title:... E-mail:... Telephone:... Facsimile:...

More information

Notwithstanding Article 29, any invention that is liable to injure public order, morality or public health shall not be patented (Article 32).

Notwithstanding Article 29, any invention that is liable to injure public order, morality or public health shall not be patented (Article 32). Japan Patent Office (JPO) Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 2 Section 3: Experimental use and/or scientific research... 3 Section 4: Preparation of medicines...

More information

G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM

G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM THE ENLARGED BOARD OF APPEAL WILL BE WELCOME By Jean-Robert CALLON DE LAMARCK Partner European and French Patent Attorney The debate on software

More information

Chapter Patent Infringement --

Chapter Patent Infringement -- Chapter 5 -- Patent Infringement -- In this chapter, we will explore the scope of a patent and how it is determine whether a patent has been infringed. The scope of a patent, i.e., what the patent covers,

More information

Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail.

Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. (Applied to any applications to register a patent term extension filed on or after

More information

The relationship between insufficiency and clarity Clear or unclear?

The relationship between insufficiency and clarity Clear or unclear? The relationship between insufficiency and clarity Clear or unclear? Christof Keussen 24.10.2014 www.glawe.de 1 24.10.2014 Legal Sources in EP and DE Art. 83 EPC: The European patent application shall

More information

S A M P L E Q U E S T I O N S April 2002

S A M P L E Q U E S T I O N S April 2002 P A T E N T L A W L A W 6 7 7 P R O F E S S O R W A G N E R S P R I N G 2 0 0 2 April 2002 These five multiple choice questions (based on a fact pattern used in the Spring 2001 Patent Law Final Exam) are

More information

It is all crystal clear by definition... (and don t blame us if it isn t)

It is all crystal clear by definition... (and don t blame us if it isn t) It is all crystal clear by definition... (and don t blame us if it isn t) Casual observations on claim interpretation in the European Patent Office Tamás Bokor Member of the Boards of Appeal of the European

More information

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION ELI LILLY AND COMPANY, v. Plaintiff, TEVA PARENTERAL MEDICINES, INC., APP PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O., TEVA

More information

[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights

[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights [English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: EL SALVADOR... National Registration

More information

Experimental Use Exemption of Patent Infringement A Brief Comparison of China and the United States

Experimental Use Exemption of Patent Infringement A Brief Comparison of China and the United States BIOTECH BUZZ International Subcommittee January 2015 Contributors: Li Feng, PhD, Jiancheng Jiang and Yuan Wang Experimental Use Exemption of Patent Infringement A Brief Comparison of China and the United

More information

Lessons learnt 6 February 2015

Lessons learnt 6 February 2015 Patent infringement Lessons learnt from patent case law in Europe in 2013 and 2014 Véron & Associés Seminar Paris Maison de la Recherche Sabine Agé Paris Lyon Patent infringement Bolar exemption (1/2)

More information

The Same Invention or Not the Same Invention? Thorsten Bausch

The Same Invention or Not the Same Invention? Thorsten Bausch The Same Invention or Not the Same Invention? Thorsten Bausch FICPI World Congress Munich 2010 CONTENTS The Same Invention or Not the Same Invention? Practical Problems The standard of sameness the skilled

More information

Before : MR JUSTICE HENRY CARR Between : - and

Before : MR JUSTICE HENRY CARR Between : - and Neutral Citation Number: [2018] EWHC 3120 (Ch) IN THE HIGH COURT OF JUSTICE BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES CHANCERY DIVISION Case No: CH-2018-000108 Royal Courts of Justice 7 Rolls Building,

More information

Going full circle: Bolar in Europe and the UPC

Going full circle: Bolar in Europe and the UPC Going full circle: Bolar in Europe and the UPC ENGLAND, ROYLE AND DE COSTER : GOING FULL CIRCLE: BOLAR IN EUROPE AND THE UPC : VOL 14 ISSUE 2 BSLR 1 Article 10(6) of the Directive provides that the following

More information

[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights

[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Chile... Office: National Institute of Industrial Property (INAPI)...

More information

ROMANIA Patent Law NO.64/1991 OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014

ROMANIA Patent Law NO.64/1991 OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014 ROMANIA Patent Law NO.64/1991 OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014 TABLE OF CONTENTS CHAPTER I - GENERAL PROVISIONS Art. 1 Art. 2 Art. 3 Art. 4 Art. 5 CHAPTER II - PATENTABLE INVENTIONS

More information

Before: MR. JUSTICE HENRY CARR Between:

Before: MR. JUSTICE HENRY CARR Between: Neutral Citation Number: [2017] EWHC 2880 (Pat) Case No: HP-2014-000040 HP-2015-000012, HP-2015-000048 and HP-2015-000062 IN THE HIGH COURT OF JUSTICE BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES

More information

Patent Cooperation Treaty (PCT) Working Group

Patent Cooperation Treaty (PCT) Working Group E PCT/WG/5/17 ORIGINAL: ENGLISH DATE: APRIL 3, 2012 Patent Cooperation Treaty (PCT) Working Group Fifth Session Geneva, May 29 to June 1, 2012 REVISION OF WIPO STANDARD ST.14 Document prepared by the International

More information

OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014 REPUBLICATION PATENT LAW NO.64/1991 1

OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014 REPUBLICATION PATENT LAW NO.64/1991 1 OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014 REPUBLICATION PATENT LAW NO.64/1991 1 CHAPTER I - GENERAL PROVISIONS Art. 1 - (1) The rights in inventions shall be recognized and protected on

More information

The Royal Society of Chemistry IP Law Case Seminar: 2017 in the U.S.

The Royal Society of Chemistry IP Law Case Seminar: 2017 in the U.S. Finnegan, Henderson, Farabow, Garrett & Dunner, LLP The Royal Society of Chemistry IP Law Case Seminar: 2017 in the U.S. Anthony C. Tridico, Ph.D. 2017 1 Agenda U.S. Supreme Court news 2017 U.S. Court

More information

Second Medical Use Patents in Europe: Are the UK and Germany Swapping Approaches?

Second Medical Use Patents in Europe: Are the UK and Germany Swapping Approaches? WHITE PAPER January 2019 Second Medical Use Patents in Europe: Are the UK and Germany Swapping Approaches? The UK Supreme Court s ruling in Warner Lambert v Actavis resulted from deliberations over the

More information

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW Since 1957 500 MEMORIAL ST. POST OFFICE BOX 2049 DURHAM, NORTH CAROLINA 27702-2049 (919) 683-5514 GENERAL RULES PERTAINING TO PATENT INFRINGEMENT Patent infringement

More information

Europe Divided Update on National Case Law in Europe

Europe Divided Update on National Case Law in Europe Europe Divided Update on National Case Law in Europe Leythem Wall 29 November 2011 European Patents 38 EPC Member States as of 1 January 2011 Centralized prosecution Bundle of national patents Articles

More information

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:

Questionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of: The answers to this questionnaire have been provided on behalf of: Country: Germany Office: Federal Ministry of Justice and for Consumer Protection / German Patent and Trademark Office Person to be contacted:

More information

The use of prosecution history in post-grant patent proceedings

The use of prosecution history in post-grant patent proceedings Question Q229 National Group: Netherlands Title: The use of prosecution history in post-grant patent proceedings Contributors: Reporter within Working Committee: John ALLEN (Chair), Bas Berghuis van Woortman,

More information

November Obvious To Try In Pharmaceutical Formulations. g Motivation To Combine. g Obviousness-Type Double Patenting

November Obvious To Try In Pharmaceutical Formulations. g Motivation To Combine. g Obviousness-Type Double Patenting Federal Circuit Review Obviousness Volume Two Issue Two November 2009 In This Issue: g Obvious To Try In Pharmaceutical Formulations g Motivation To Combine g Obviousness-Type Double Patenting = Product-Process

More information